The continuous debate in literature about the usage of iodine-131 dosing for the ablation of thyroid remnants and metastases.

There is no fulltext present in this item.

Title:	The continuous debate in literature about the usage of iodine-131 dosing for the ablation of thyroid remnants and metastases.
Author(s):	Klerk, J.M. de; Oyen, W.J.G.
Publication year:	2009
Source:	Minerva Endocrinologica, vol. 34, iss. 1, (2009), pp. 57-69
ISSN:	0391-1977
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/81336
Display more details
Subject:	ONCOL 3: Translational research ONCOL 5: Aetiology, screening and detection
Organization:	Nuclear Medicine
Journal title:	Minerva Endocrinologica
Volume:	vol. 34
Issue:	iss. 1
Page start:	p. 57
Page end:	p. 69
Abstract:	Radioiodine plays an important role in the treatment of thyroid cancer. It is used for thyroid remnant ablation as well as for treatment of metastatic disease. Despite the fact that it is used all over the world for these indications, the exact administered dose is still a subject for DISCUSSION: Two methods are widely available: the so-called fixed empiric method and the dosimetric one. This review will highlight the aspects of radioiodine in treatment of thyroid cancer and discuss the advantages and disadvantages of the several methods for the calculation of the administered dose.